KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Moderna (MRNA) Receivables - Net (2017 - 2025)

Moderna (MRNA) has disclosed Receivables - Net for 9 consecutive years, with $368.0 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net fell 47.28% to $368.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $368.0 million through Dec 2025, down 47.28% year-over-year, with the annual reading at $368.0 million for FY2025, 47.28% down from the prior year.
  • Receivables - Net for Q4 2025 was $368.0 million at Moderna, down from $1.0 billion in the prior quarter.
  • The five-year high for Receivables - Net was $3.2 billion in Q1 2021, with the low at $36.0 million in Q2 2025.
  • Average Receivables - Net over 5 years is $1.6 billion, with a median of $1.2 billion recorded in 2022.
  • The sharpest move saw Receivables - Net skyrocketed 57047.94% in 2021, then tumbled 91.38% in 2023.
  • Over 5 years, Receivables - Net stood at $3.2 billion in 2021, then crashed by 56.38% to $1.4 billion in 2022, then tumbled by 35.6% to $892.0 million in 2023, then fell by 21.75% to $698.0 million in 2024, then crashed by 47.28% to $368.0 million in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $368.0 million, $1.0 billion, and $36.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.